In addition, tumors of mice treated with anti-GITR displayed large numbers of infiltrating activated T cells, and DTA-1 treatment increased the number of IFN-γ secreting T cells, which was required for tumor rejection [76]. This evidence concerns the gene TNFRSF18 and neoplasm.